November 11, 2024

Hunter Richman (Yu group) makes contributions to the field of nanomedicine as co-author on a preprint paper published in F1000 Research. The paper, titled Quantitative cytotoxicity analysis of antibacterial Janus nanoparticles in immune and cancer cells, explores the potential of amphiphilic Janus nanoparticles as a promising alternative to traditional antibiotics in combating multi-drug-resistant bacteria. Congrats Hunter!